Author name: David Lambert

Dr Lambert is a principal, managing partner and chief informatics officer of CE Dojo, and former affiliate consultant to Old Well Consulting responsible for their eLearning platform. Dr Lambert is a Diplomate of the American Board of Oral & Maxillofacial Surgery and former clinical pharmacist. Dr Lambert is former Assistant Professor of Oral & Maxillofacial Surgery at the Oregon Health & Sciences University in Portland, Oregon where he also studied Clinical Informatics within the Department of Medical Informatics and Clinical Epidemiology. Dr Lambert has lectured extensively on topics of surgery, pharmacology, the opiate crisis and is published within several peer-reviewed journals.

The UK Personal Independence Payment Database – Should Spiraling Disabilities Give Pause To Reconsider Continued Routine Office Based Anesthesia In Dentistry Without Further Consideration?

Former Blackrock hedge fund analyst Ed Dowd made a troubling discovery about mortality rates in the US. He observed an increase in deaths, particularly among young individuals, unrelated to COVID-19. Insurance companies also reported higher death rates. Dowd’s research team has now found startling data from the UK indicating a significant rise in disabilities coinciding with the mass vaccination effort. Dowd believes the same trend is likely happening in the US. This raises concerns, especially in dentistry, where an increase in cardiovascular disabilities among young patients has been observed. A more cautious approach to office-based anesthesia may be necessary.

The UK Personal Independence Payment Database – Should Spiraling Disabilities Give Pause To Reconsider Continued Routine Office Based Anesthesia In Dentistry Without Further Consideration? Read More »

Fluoride: A Second Look…

Many of us learned about the advantages of fluoride in dental school. However, in the post-COVID pandemic era, people are reevaluating widely accepted beliefs, including fluoride. Anti-fluoridation proponents have presented valid arguments.   Join the Socratic Dental Alliance and watch a video of a recent meeting with two notable advocates, Rick North and Barbara Tritz, to

Fluoride: A Second Look… Read More »

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners

The US Drug Enforcement Administration (DEA) has outlined an eight-hour training requirement on the treatment and management of opioid patients. The Medication Access and Training Expansion Act mandates the training for all DEA-registered providers, with the deadline for completion set for the date of a practitioner’s next scheduled DEA registration submission beginning on June 27. Graduates from medical and dental schools are exempt from the requirement. The training does not have to occur in one session, and courses previously undertaken in accordance with state-mandated continuing education will apply.

DEA Issues Guidance on Opioid Treatment Training for Medical Practitioners Read More »

FDA Approves OTC Naloxone

This article discusses the recent approval of the first over-the-counter naloxone nasal spray for use in reversing opioid overdoses. The U.S. Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) naloxone nasal spray, Narcan, to help prevent opioid overdoses. The nasal spray is intended for use in adults and adolescents, and the FDA

FDA Approves OTC Naloxone Read More »

Shopping Cart
Scroll to Top
0